cyclosporine and Melanoma

cyclosporine has been researched along with Melanoma in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (25.64)18.2507
2000's14 (35.90)29.6817
2010's13 (33.33)24.3611
2020's2 (5.13)2.80

Authors

AuthorsStudies
Cerqueira, F; Florêncio, MH; Justino, F; Marcelo-Curto, MJ; Moiteiro, C; Nascimento, MS; Pedro, M; Pinto, MM; Tavares, R1
Arancia, G; Condello, M; Corinti, S; Cosentino, D; Di Felice, G; Gallo, FR; Meschini, S; Multari, G1
Gajewski, TF; Luke, JJ; Olson, DJ; Rajagopal, P; Tjota, MY; Venkataraman, G1
Arance, A; Ordás, I; Pesántez, D; Seguí, E; Viladot, M1
Ascha, M; Ascha, MS; Bordeaux, JS; Tanenbaum, J1
Arndt, S; Bosserhoff, AK; Fischer, MJM; Gebhardt, L; Karrer, S; Schneider, C; Zimmermann, JL1
Carranza, A; Coveñas, R; González-Ortega, A; Muñoz, M; Ramiro-Fuentes, S; Salinas-Martín, MV; Sánchez-Vaderrábanos, E1
Abramson, AK; Day, A; Menter, MA; Patel, M; Warren, RB1
Akhavanpoor, M; Bruckner, T; Darche, FF; Doesch, AO; Ehlermann, P; Erbel, C; Frankenstein, L; Gleissner, CA; Helmschrott, M; Katus, HA; Klein, B; Rivinius, R; Ruhparwar, A; Schmack, B; Thomas, D1
Dotor, A; González-Herrada, C; Lapresta, A1
Gergely, P; Hajdú, T; Juhász, T; Katona, É; Kókai, E; Rácz, K; Somogyi, CS; Szász, C; Zákány, R1
Diem, S; Larkin, J; Spain, L1
Fodor, J; Gergely, P; Juhász, T; Matta, C; Molnár, Z; Nagy, G; Szíjgyártó, Z; Veress, G; Zákány, R1
Allshire, A; Anoopkumar-Dukie, S; Conere, T; Sisk, GD1
Cervinka, M; Rudolf, E; Rudolf, K1
Eagle, RC; Edward, DP; Fontanilla, FA; Goldstein, DA; Tessler, HH; Wong, M1
Martin, L1
Arcese, A; Camplone, G; Carlesimo, M; Di Russo, PP; Gamba, A; La Pietra, M; Mari, E; Orsini, D1
Berger, W; Bilban, M; Bracher, A; Heinz, M; Knöfler, M; Loewe, R; Niederleithner, H; Pehamberger, H; Petzelbauer, P; Sonderegger, S; Tauber, S1
Anichini, A; Baldassari, P; Bersani, I; Dal Col, J; Dolcetti, R; Molla, A; Mortarini, R; Perotti, V; Tassi, E; Vegetti, C1
Blanco, G; Diebold, Y; Domingo, E; Fernández, N; Lopez, R; Mayo-Iscar, A; Morilla-Grasa, A; Ordoñez, JL; Rabano, G; Saornil, MA1
Andrassy, J; Geissler, EK; Graeb, C; Guba, M; Jauch, KW; Koehl, GE; Kroemer, A; Richter, S; Scherer, MN; Schlitt, HJ; Steinbauer, M1
Feun, L; Hurley, J; Marini, A; Mazumder, A; Moffat, F; Savaraj, N1
Antin, J; Granter, S; Hodi, FS1
Birkholz, K; Dörrie, J; Ferrone, S; Fey, GH; Kämpgen, E; Kellner, C; Kügler, M; Nettelbeck, DM; Peipp, M; Schaft, N; Schuler-Thurner, B; Schwemmlein, M; Schwenkert, M1
Fenton, RG; Peltz, G; Taub, DD; Turcovski-Corrales, SM1
Kautzky, F; Köhler, LD; Vogt, HJ1
Bellamy, J; Benoit, G; Blanchet, P; Charpentier, B; Hiesse, C; Kriaa, F; Larue, JR1
de Waard-Siebinga, I; de Wolff-Rouendaal, D; Jager, M; van Delft, JL1
Gragoudas, ES; Hu, LK; Huh, K; Young, LH1
Kan-Mitchel, J; Liggett, PE; Lo, G; Pascal, SG; Pince, KJ; Rao, NA1
Ackerman, S; Ernstoff, MS; Jones, H; Kirkwood, JM; Saria, EA; Schwartz, R; Selvaggi, K; Vlock, DR; Wedel, N1
Czyz, W; Sobczak-Radwan, K; Szepietowski, J; Szepietowski, T; Wasik, F; Włodarczyk, M1
Arancia, G; Calcabrini, A; Cianfriglia, M; Del Bufalo, D; Meschini, S; Molinari, A; Stringaro, A1
Dong, H; Hirpara, JL; Kini, RM; Loh, KW; Pervaiz, S; Seyed, MA1
Bacin, F; Bonicel, P; Kemeny, JL; Madelmont, JC; Michelot, J; Moins, N; Morvan, D; Papon, J1
Bradford, B; Enomoto, N; Ikejema, K; Rose, ML; Rusyn, I; Schemmer, P; Seabra, V; Stacklewitz, RF; Thurman, RG; Wheeler, MD; Yin, M; Zhong, Z1
Grubb, DR; Johnson, KL; Lawen, A; Ly, JD; Vaillant, F1
Amenábar, JJ; Gaínza, FJ; Gómez-Ullate, P; Lampreabe, I; Urbizu, JM; Zárraga, S1

Reviews

5 review(s) available for cyclosporine and Melanoma

ArticleYear
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.
    Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:5

    Topics: Aortic Coarctation; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Dermatologic Agents; Eye Abnormalities; Eye Diseases; Eyelid Neoplasms; Humans; Lymphoma, T-Cell, Cutaneous; Melanoma; Mohs Surgery; Multiple Myeloma; Neurocutaneous Syndromes; Retinoids; Sebaceous Gland Neoplasms; Skin Diseases; Skin Neoplasms; Stevens-Johnson Syndrome; Syndrome; Tumor Necrosis Factor-alpha

2014
Management of toxicities of immune checkpoint inhibitors.
    Cancer treatment reviews, 2016, Volume: 44

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Antineoplastic Agents; Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Colitis; CTLA-4 Antigen; Cyclosporine; Diarrhea; Drug Eruptions; Humans; Immunosuppressive Agents; Infliximab; Ipilimumab; Kidney Neoplasms; Lung Neoplasms; Melanoma; Mycophenolic Acid; Neoplasms; Nivolumab; Pituitary Diseases; Programmed Cell Death 1 Receptor; Skin Neoplasms; Tacrolimus; Thyroiditis

2016
[What's new in dermatological treatments?].
    Annales de dermatologie et de venereologie, 2010, Volume: 137 Suppl 4

    Topics: Adenine; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cyclosporine; Dermatofibrosarcoma; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Follow-Up Studies; Gels; HIV Infections; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Ipilimumab; Melanoma; Neoplasm Staging; Organophosphonates; Piperazines; Psoriasis; Pyrimidines; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Survival Analysis; Tenofovir; Treatment Outcome; Ustekinumab

2010
Glycine: a new anti-inflammatory immunonutrient.
    Cellular and molecular life sciences : CMLS, 1999, Nov-30, Volume: 56, Issue:9-10

    Topics: Alcohols; Animals; Anti-Inflammatory Agents; Calcium Channels, L-Type; Chloride Channels; Cyclosporine; Free Radicals; Glycine; Hepatitis, Alcoholic; Humans; Hypoxia; Inflammation; Kupffer Cells; Leukocytes; Melanoma; Reperfusion Injury; Shock, Septic; Taurine

1999
[Presentation of cancers in recipients of a solid-organ transplant].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2001, Volume: 21, Issue:6

    Topics: Carcinogens; Cell Transformation, Neoplastic; Cyclosporine; Genetic Predisposition to Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Melanoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogenes; Postoperative Complications; Prevalence; Recurrence; Risk; Sarcoma, Kaposi; Skin Neoplasms; Transplantation; Tumor Virus Infections; Ultraviolet Rays

2001

Trials

2 trial(s) available for cyclosporine and Melanoma

ArticleYear
Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanoma.
    Cancer investigation, 2005, Volume: 23, Issue:1

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclosporine; Dacarbazine; Female; Humans; Immunosuppressive Agents; Interferon-alpha; Interleukin-2; Male; Melanoma; Skin Neoplasms; Tamoxifen; Treatment Outcome

2005
Phase I/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-Mel) immunoconjugate plus cyclosporine A in patients with metastatic melanoma.
    Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy, 1993, Volume: 13, Issue:3

    Topics: Aged; Animals; Antibodies, Monoclonal; Antibody Formation; Combined Modality Therapy; Cyclosporine; Female; Humans; Immunotoxins; Male; Melanoma; Mice; Middle Aged; Ricin

1993

Other Studies

32 other study(ies) available for cyclosporine and Melanoma

ArticleYear
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro.
    Journal of natural products, 2001, Volume: 64, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Lung Neoplasms; Lymphocytes; Magnetic Resonance Spectroscopy; Melanoma; Molecular Structure; Oxidation-Reduction; Portugal; Quercus; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured

2001
Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts.
    Journal of natural products, 2014, Apr-25, Volume: 77, Issue:4

    Topics: Alkaloids; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fibroblasts; Fluorescent Antibody Technique; Humans; Ibogaine; Melanoma; Molecular Structure; Osteosarcoma

2014
A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab.
    Journal for immunotherapy of cancer, 2020, Volume: 8, Issue:1

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Female; Humans; Ipilimumab; Melanoma; Nivolumab; Prognosis

2020
Successful management of refractory immune-mediated enterocolitis with cyclosporine.
    European journal of cancer (Oxford, England : 1990), 2020, Volume: 131

    Topics: Adult; Antineoplastic Agents, Immunological; Biopsy; Colon; Colonoscopy; Cyclosporine; Drug Resistance; Enterocolitis; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Melanoma; Methylprednisolone; Programmed Cell Death 1 Receptor; Skin Neoplasms; Treatment Outcome

2020
Risk Factors for Melanoma in Renal Transplant Recipients.
    JAMA dermatology, 2017, 11-01, Volume: 153, Issue:11

    Topics: Adult; Age Factors; Aged; Cohort Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Male; Melanoma; Middle Aged; Registries; Risk Factors; Sirolimus; Skin Neoplasms; Time Factors; Tissue Donors; Transplant Recipients; United States

2017
Cold atmospheric plasma causes a calcium influx in melanoma cells triggering CAP-induced senescence.
    Scientific reports, 2018, 07-03, Volume: 8, Issue:1

    Topics: Aging; Calcium; Calcium Channels; Cell Line, Tumor; Chelating Agents; Cold Temperature; Cryotherapy; Cyclosporine; Endoplasmic Reticulum; Humans; Melanoma; Mitochondria; Plasma Gases; Ryanodine

2018
Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
    Peptides, 2014, Volume: 55

    Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclosporine; Drug Screening Assays, Antitumor; Female; Gene Expression; HEK293 Cells; Humans; Inhibitory Concentration 50; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Uveal Neoplasms; Young Adult

2014
Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Melanoma; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Neoplasms; Risk Factors; Skin Neoplasms; Survival Analysis; Tacrolimus

2015
Toxic epidermal necrolysis induced by vemurafenib.
    Actas dermo-sifiliograficas, 2015, Volume: 106, Issue:8

    Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Combined Modality Therapy; Cyclosporine; Drug Substitution; Humans; Indoles; Ipilimumab; Lung Neoplasms; Male; Melanoma; Neoplasm Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Stevens-Johnson Syndrome; Sulfonamides; Vemurafenib

2015
PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines.
    International journal of oncology, 2016, Volume: 48, Issue:3

    Topics: Calcineurin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclosporine; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation, Neoplastic; Glucuronosyltransferase; Humans; Hyaluronan Receptors; Hyaluronan Synthases; Hyaluronic Acid; MAP Kinase Signaling System; Melanoma; Phosphoproteins; Phosphorylation; Protein Phosphatase 2

2016
Inhibition of calcineurin by cyclosporine A exerts multiple effects on human melanoma cell lines HT168 and WM35.
    International journal of oncology, 2009, Volume: 34, Issue:4

    Topics: Apoptosis; Calcineurin Inhibitors; Calcium; Calmodulin; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Cytosol; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Melanoma; Psoriasis; RNA, Messenger

2009
Mitochondrial modulation of oxygen-dependent radiosensitivity in some human tumour cell lines.
    The British journal of radiology, 2009, Volume: 82, Issue:982

    Topics: Anti-Bacterial Agents; bcl-2-Associated X Protein; Bongkrekic Acid; Breast Neoplasms; Cell Line, Tumor; Cyclosporine; Female; Humans; Immunosuppressive Agents; Melanoma; Mitochondria; Oxidative Stress; Radiation Tolerance; Tacrolimus; Uterine Cervical Neoplasms

2009
Cytotoxicity and mitochondrial apoptosis induced by etoposide in melanoma cells.
    Cancer investigation, 2009, Volume: 27, Issue:7

    Topics: Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Apoptosis; Ataxia Telangiectasia Mutated Proteins; bcl-2-Associated X Protein; Benzothiazoles; Caspase 2; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Cycle Proteins; Cyclosporine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA Damage; DNA-Binding Proteins; Etoposide; Humans; Melanoma; Mitochondria; Neoplasm Proteins; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Superoxides; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2009
Juvenile xanthogranuloma masquerading as melanoma.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2009, Volume: 13, Issue:5

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Child; Chlorambucil; Cyclosporine; Diagnosis, Differential; Drug Resistance; Humans; Immunosuppressive Agents; Male; Melanoma; Prednisone; Skin Neoplasms; Visual Acuity; Xanthogranuloma, Juvenile

2009
Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.
    International journal of dermatology, 2012, Volume: 51, Issue:10

    Topics: Acitretin; Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Melanoma; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Skin Neoplasms; Treatment Outcome; Tumor Necrosis Factor-alpha

2012
Wnt1 is anti-lymphangiogenic in a melanoma mouse model.
    The Journal of investigative dermatology, 2012, Volume: 132, Issue:9

    Topics: Animals; Cyclosporine; Disease Models, Animal; Female; Humans; Lymphangiogenesis; Lymphatic Metastasis; Melanoma; Mice; Mice, Inbred C57BL; Mice, SCID; Skin Neoplasms; Tumor Cells, Cultured; Vascular Endothelial Growth Factor C; Wnt Signaling Pathway; Wnt1 Protein

2012
NFATc2 is a potential therapeutic target in human melanoma.
    The Journal of investigative dermatology, 2012, Volume: 132, Issue:11

    Topics: Apoptosis; Calcineurin; Caspase 2; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Cysteine Endopeptidases; Down-Regulation; Enzyme Inhibitors; Humans; Inhibitor of Apoptosis Proteins; MAP Kinase Signaling System; Melanoma; NFATC Transcription Factors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; TNF-Related Apoptosis-Inducing Ligand

2012
The need for continuous immunosuppression with cyclosporin A to maintain an experimental model of uveal melanoma.
    Melanoma research, 2002, Volume: 12, Issue:5

    Topics: Animals; Body Weight; Cyclosporine; Disease Models, Animal; Humans; Immunosuppressive Agents; Male; Melanoma; Mitosis; Neoplasms, Experimental; Rabbits; Time Factors; Tumor Cells, Cultured; Uvea; Uveal Neoplasms

2002
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice.
    Transplantation, 2004, May-15, Volume: 77, Issue:9

    Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, SCID; Sirolimus; Skin Neoplasms; Transplantation, Homologous

2004
Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report.
    Cancer immunity, 2005, May-19, Volume: 5

    Topics: Anemia, Aplastic; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Melanoma; Remission Induction; Sirolimus; Tacrolimus

2005
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells.
    Melanoma research, 2008, Volume: 18, Issue:2

    Topics: ADP Ribose Transferases; Apoptosis; Bacterial Toxins; Cell Line, Tumor; Chondroitin Sulfate Proteoglycans; Cyclosporine; Cytotoxicity, Immunologic; Exotoxins; Humans; Immunosuppressive Agents; Immunotherapy; Immunotoxins; Melanoma; Pseudomonas aeruginosa Exotoxin A; Recombinant Fusion Proteins; Tumor Cells, Cultured; Virulence Factors

2008
CD28:B7 interactions promote T cell adhesion.
    European journal of immunology, 1995, Volume: 25, Issue:11

    Topics: Abatacept; Androstadienes; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; B7-1 Antigen; CD28 Antigens; Cell Adhesion; Cell Adhesion Molecules; CTLA-4 Antigen; Cyclosporine; Enzyme Inhibitors; Humans; Immunoconjugates; Immunosuppressive Agents; Integrins; Melanoma; T-Lymphocytes; Transfection; Tumor Cells, Cultured; Wortmannin

1995
[Multiple cutaneous neoplasms in cyclosporine therapy after kidney transplantation].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1995, Volume: 46, Issue:9

    Topics: Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cyclosporine; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysplastic Nevus Syndrome; Follow-Up Studies; Humans; Immune Tolerance; Kidney Transplantation; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Precancerous Conditions; Skin Neoplasms

1995
Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients.
    Transplantation proceedings, 1995, Volume: 27, Issue:4

    Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Leukemia; Lymphoma; Male; Melanoma; Neoplasms; Risk Factors; Skin Neoplasms; Time Factors

1995
Hamster Greene melanoma in the rabbit eye: immunosuppressive treatment to improve this tumor model.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1994, Volume: 232, Issue:11

    Topics: Animals; Anterior Chamber; Cricetinae; Cyclosporine; Disease Models, Animal; Eye Neoplasms; Female; Immune Tolerance; Immunization; Melanoma; Necrosis; Neoplasm Transplantation; Rabbits

1994
Establishment of pigmented choroidal melanomas in a rabbit model.
    Retina (Philadelphia, Pa.), 1994, Volume: 14, Issue:3

    Topics: Animals; Choroid Neoplasms; Cyclosporine; Disease Models, Animal; Fundus Oculi; Humans; Immunosuppression Therapy; Melanoma; Neoplasm Transplantation; Rabbits; Tumor Cells, Cultured

1994
Heterotransplantation of human uveal melanoma.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1993, Volume: 231, Issue:1

    Topics: Aged; Aged, 80 and over; Animals; Choroid Neoplasms; Cyclosporine; Disease Models, Animal; Eye Enucleation; Female; Fundus Oculi; Graft Rejection; Humans; Immunosuppression Therapy; Melanoma; Neoplasm Transplantation; Rabbits; Transplantation, Heterologous; Tumor Cells, Cultured; Ultrasonography

1993
Excess benign melanocytic naevi in renal transplant recipients.
    Dermatology (Basel, Switzerland), 1997, Volume: 194, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Back; Buttocks; Case-Control Studies; Cyclosporine; Follow-Up Studies; Foot Diseases; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Melanoma; Middle Aged; Nevus, Pigmented; Prednisone; Prevalence; Risk Factors; Skin Neoplasms; Time Factors; Transplantation, Homologous

1997
Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells.
    International journal of cancer, 1998, Mar-16, Volume: 75, Issue:6

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Compartmentation; Cells, Cultured; Cyclosporine; DNA-Binding Proteins; Doxorubicin; Fluorescent Antibody Technique, Indirect; Gene Expression; Golgi Apparatus; Humans; Melanoma; Microscopy, Confocal; Multidrug Resistance-Associated Proteins; MutS Homolog 3 Protein; Probenecid; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured

1998
Induction of mitochondrial permeability transition and cytochrome C release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells.
    Blood, 2000, Mar-01, Volume: 95, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Caspase Inhibitors; Caspases; Cyclosporine; Cytochrome c Group; Cytosol; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fluorescence; HL-60 Cells; Humans; Intracellular Membranes; Melanoma; Mitochondria; Mitochondria, Liver; Neoplasm Proteins; Oligopeptides; Permeability; Photochemistry; Pyrimidinones; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Signal Transduction; Skin Neoplasms; Staurosporine; Tumor Cells, Cultured

2000
Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma.
    Melanoma research, 2000, Volume: 10, Issue:5

    Topics: Animals; Biopsy; Cell Culture Techniques; Choroid Neoplasms; Cyclosporine; Female; Humans; Immunosuppressive Agents; Melanoma; Neoplasm Transplantation; Rabbits; Transplantation, Heterologous; Tumor Cells, Cultured; Uveal Neoplasms

2000
Mitochondrial cytochrome c release is caspase-dependent and does not involve mitochondrial permeability transition in didemnin B-induced apoptosis.
    Oncogene, 2001, Jul-05, Volume: 20, Issue:30

    Topics: Apoptosis; Bongkrekic Acid; Burkitt Lymphoma; Calcium Signaling; Caspase 9; Caspases; Cyclosporine; Cytochrome c Group; Depsipeptides; DNA Fragmentation; Enzyme Activation; HL-60 Cells; Humans; Intracellular Membranes; Ion Channels; Melanoma; Membrane Potentials; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Peptides, Cyclic; Permeability; Thapsigargin; Tumor Cells, Cultured

2001